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The systematic review by Bleich and colleagues contributes to the
much needed evidence supporting management of patients with
multiple chronic conditions — multimorbidity. Although the re-
view’s focus is  the United States,  it  addresses an issue that  is
highly relevant to all  health care systems and raises important
questions about how we can design systems to address the needs
of this vulnerable group (1). Literature is now well-established on
the impact of multimorbidity on patients, health care providers,
and health care systems (2,3), but less is known about interven-
tions that can improve outcomes in this group of patients (4).
The systematic review of Bleich et al provides evidence from 27
studies that  examined 5 models of  care and suggests  that  care
management,  case  management,  and  disease  management  are
promising models for people with multimorbidity. This finding
seems to fit with our intuitive sense that care coordination will re-
duce the challenges experienced by people with multiple chronic
conditions, related polypharmacy, and high use of health care ser-
vices (5). However, evidence from other settings does not yet sup-
port a move to widespread implementation of case management
for multimorbidity, and many questions remain regarding the op-
timal design of such programs (6). In addition, we need to avoid
imposing an additional treatment burden on a population that is
already struggling with potential over-exposure to medical care
(7).
The review of Bleich et al also highlights the heterogeneity within
the population of people with multiple chronic conditions and their
overlap  with  other  patient  groups  in  relation to  disability  and
frailty. Definitions of multimorbidity and related constructs such
as comorbidity continue to be debated (8), but the definition of
multimorbidity as 2 or more conditions can be regarded as the
norm now, for older people in particular (9). Current evidence
suggests that we need to focus on the subgroup of patients with
multiple conditions who can be regarded as having complex mul-
timorbidity on the basis of a high number of conditions, polyphar-
macy, and high health care use (10). These definitional and opera-
tional  aspects  of  multimorbidity  highlight  the  importance  of
clearly reporting patient characteristics and settings when evaluat-
ing interventions for these patients. Reporting is essential to allow
consideration of external validity or generalizability of multimor-
bidity interventions for those considering introducing interven-
tions in other settings (11).
An additional key issue that Bleich et al discuss is the need for ap-
propriate comparison or control groups to allow for robust evalu-
ation.  Ideally,  randomized  trials  would  be  employed  that  use
cluster and stepped wedge designs where appropriate. Only 13 of
the 27 studies included in this review were randomized controlled
trials  (RCTS),  which  may  partially  explain  the  differences
between Bleich’s review and the related Cochrane review. The
Cochrane review included only RCTs and not less robust study
designs,  and the  included studies  were  from a  wider  range of
countries, including the United States (4). Variations in outcomes
reported across different studies are also challenging, and work is
ongoing to develop a  core outcome set  for  multimorbidity re-
search.
The systematic review of Bleich et al highlights the need for fur-
ther evidence to support policy and management of patients with
complex multimorbidity. In the meantime, studies should be de-
signed to allow robust evaluation of interventions and should build
on the evidence from this and related reviews that suggest a health
care focus on patient-centered outcomes for patients with mul-
timorbidity.
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